Appendix Table 2.
Intensification of Oral Antidiabetes Medication and Insulin
| Initiation of oral medication | Initiation of insulin | |||
|---|---|---|---|---|
| N=116,675 | N=303,729 | |||
| HR | CI | HR | CI | |
| MOVE! Participation | 0.81 | 0.78–0.85 | 0.95 | 0.92–0.98 |
Models also controlled for Charlson Comorbidity Index, smoking status, coronary artery disease, COPD, osteoarthritis, mental health conditions (depression and psychoses), distance from a patient’s zipcode to a facility offering MOVE!, marital status, number of primary care visits per year, diabetes duration in years, and years of care in the VA system. Other factors considered for inclusion in analysis but omitted through AIC model selection included heart failure, PTSD, alcohol abuse, and drug abuse. Models were adjusted for clustering by clinic, and included propensity scores to adjust for likelihood of MOVE! participation. Hazard ratios reflect 1-unit change for continuous variables.